206 related articles for article (PubMed ID: 18727058)
1. Kinetics of H2AX phosphorylation after exposure to cisplatin.
Olive PL; Banáth JP
Cytometry B Clin Cytom; 2009 Mar; 76(2):79-90. PubMed ID: 18727058
[TBL] [Abstract][Full Text] [Related]
2. Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.
Clingen PH; Wu JY; Miller J; Mistry N; Chin F; Wynne P; Prise KM; Hartley JA
Biochem Pharmacol; 2008 Jul; 76(1):19-27. PubMed ID: 18508035
[TBL] [Abstract][Full Text] [Related]
3. Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin.
Huang X; Okafuji M; Traganos F; Luther E; Holden E; Darzynkiewicz Z
Cytometry A; 2004 Apr; 58(2):99-110. PubMed ID: 15057963
[TBL] [Abstract][Full Text] [Related]
4. Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines.
Banáth JP; Macphail SH; Olive PL
Cancer Res; 2004 Oct; 64(19):7144-9. PubMed ID: 15466212
[TBL] [Abstract][Full Text] [Related]
5. Increased γ-H2AX and Rad51 DNA Repair Biomarker Expression in Human Cell Lines Resistant to the Chemotherapeutic Agents Nitrogen Mustard and Cisplatin.
Adam-Zahir S; Plowman PN; Bourton EC; Sharif F; Parris CN
Chemotherapy; 2014; 60(5-6):310-20. PubMed ID: 26138778
[TBL] [Abstract][Full Text] [Related]
6. Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assay.
Almeida GM; Duarte TL; Steward WP; Jones GD
DNA Repair (Amst); 2006 Feb; 5(2):219-25. PubMed ID: 16253571
[TBL] [Abstract][Full Text] [Related]
7. Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy.
Wynne P; Newton C; Ledermann JA; Olaitan A; Mould TA; Hartley JA
Br J Cancer; 2007 Oct; 97(7):927-33. PubMed ID: 17848946
[TBL] [Abstract][Full Text] [Related]
8. DNA-protein cross-links and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against human breast cancer cells.
Meng LH; Kohlhagen G; Liao ZY; Antony S; Sausville E; Pommier Y
Cancer Res; 2005 Jun; 65(12):5337-43. PubMed ID: 15958581
[TBL] [Abstract][Full Text] [Related]
9. Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays.
MacPhail SH; Banáth JP; Yu TY; Chu EH; Lambur H; Olive PL
Int J Radiat Biol; 2003 May; 79(5):351-8. PubMed ID: 12943243
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 attenuates cisplatin-induced gammaH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer.
Jeon JH; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS
Cancer Lett; 2008 Dec; 272(2):232-41. PubMed ID: 18762365
[TBL] [Abstract][Full Text] [Related]
11. Residual gammaH2AX foci as an indication of lethal DNA lesions.
Banáth JP; Klokov D; MacPhail SH; Banuelos CA; Olive PL
BMC Cancer; 2010 Jan; 10():4. PubMed ID: 20051134
[TBL] [Abstract][Full Text] [Related]
12. Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: implications for predictive testing.
Almeida GM; Duarte TL; Farmer PB; Steward WP; Jones GD
Int J Cancer; 2008 Apr; 122(8):1810-9. PubMed ID: 18074354
[TBL] [Abstract][Full Text] [Related]
13. Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation.
Mahrhofer H; Bürger S; Oppitz U; Flentje M; Djuzenova CS
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):573-80. PubMed ID: 16414372
[TBL] [Abstract][Full Text] [Related]
14. New distinct compartments in the G2 phase of the cell cycle defined by the levels of γH2AX.
Dale Rein I; Stokke C; Jalal M; Myklebust JH; Patzke S; Stokke T
Cell Cycle; 2015; 14(20):3261-9. PubMed ID: 26317799
[TBL] [Abstract][Full Text] [Related]
15. Predicting Radiosensitivity with Gamma-H2AX Foci Assay after Single High-Dose-Rate and Pulsed Dose-Rate Ionizing Irradiation.
van Oorschot B; Hovingh S; Dekker A; Stalpers LJ; Franken NA
Radiat Res; 2016 Feb; 185(2):190-8. PubMed ID: 26789702
[TBL] [Abstract][Full Text] [Related]
16. Distinct kinetics of DNA repair protein accumulation at DNA lesions and cell cycle-dependent formation of γH2AX- and NBS1-positive repair foci.
Suchánková J; Kozubek S; Legartová S; Sehnalová P; Küntziger T; Bártová E
Biol Cell; 2015 Dec; 107(12):440-54. PubMed ID: 26482424
[TBL] [Abstract][Full Text] [Related]
17. Activation of the S phase DNA damage checkpoint by mitomycin C.
Mladenov E; Tsaneva I; Anachkova B
J Cell Physiol; 2007 May; 211(2):468-76. PubMed ID: 17167777
[TBL] [Abstract][Full Text] [Related]
18. Analysis of chromate-induced DNA-protein crosslinks with the comet assay.
Merk O; Reiser K; Speit G
Mutat Res; 2000 Nov; 471(1-2):71-80. PubMed ID: 11080662
[TBL] [Abstract][Full Text] [Related]
19. Survival and induction of SOS in Escherichia coli treated with cisplatin, UV-irradiation, or mitomycin C are dependent on the function of the RecBC and RecFOR pathways of homologous recombination.
Keller KL; Overbeck-Carrick TL; Beck DJ
Mutat Res; 2001 Jun; 486(1):21-9. PubMed ID: 11356333
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cisplatin-DNA crosslinks formation with UV-C application by the alkaline Comet-assay.
Hovhannisyan GG; Haroutunyan TS; Arutyunyan RM
Exp Oncol; 2004 Sep; 26(3):240-2. PubMed ID: 15494695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
